Dedicated to Health and Longevity
I studied medicine in Houston and had the privilege of being mentored by several of the leading cardiovascular and orthopedic surgeons at the time, while working in the medical center as a surgical assistant. In the early 80’s, I left medicine and became an entrepreneur, moving back to my childhood home of Hong Kong. I was a pioneer in the exhibitions business in Asia and founded numerous other profitable businesses in various industries. During this time, I continued reading medical journals and keeping up with the latest scientific discoveries. By the late 90’s, I realized that the future of medicine would most likely lie in DNA therapy and stem cells.
Having seen the early preclinical studies on exosomes, I sincerely believe that if she had been able to get treatment with exosomes, she would be alive today.
I dedicate this Company as a legacy to my daughter and as a personal crusade to develop life-saving biologic treatments and revolutionize modern medicine to save countless lives like Annalise.
Founder and CEO
From Molecular Biologists to Blockchain Business People
With a focus on advancements in medical diagnostics and therapeutics through EV research and development, EV Biologics is building a world-class team of molecular biologists, analytical biochemists, nanoparticle biophysicists, synthetic organic chemists biomedical engineers, software and systems engineers, as well as physicians and surgeons specializing in regenerative medical technology. The motivation of our team to push back the frontiers of EV biotechnology stems from their own personal and professional experience with health and disease and the promise of next-generation solutions based on stem cell and EV therapy.
Each member of our team brings expertise in science, medicine, blockchain, AI and business that will enable EV Biologics to rapidly develop innovative medical technology for the diagnosis and treatment of disease and injury. EV Biologics is dedicated to the advancement of the science and technology of extracellular vesicles for development of the next generation of diagnostics, therapeutics and regenerative products.